Managing patient adherence and quality of life in epilepsy.
about
Strategies for improving adherence to antiepileptic drug treatment in patients with epilepsyStrategies for improving adherence to antiepileptic drug treatment in patients with epilepsyA review of medication adherence in people with epilepsy.Adherence to antiepileptic drugs among children attending a tertiary health unit in a low resource setting.Treatment of epilepsy in China: Formal or informal.Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy.Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis.Adherence to Treatment and Factors Affecting Adherence of Epileptic Patients at Yirgalem General Hospital, Southern Ethiopia: A Prospective Cross-Sectional Study.Antiepileptic Drug Nonadherence and Its Predictors among People with Epilepsy.Extended-release lamotrigine in the treatment of patients with epilepsy.Ideal characteristics of an antiepileptic drug: how do these impact treatment decisions for individual patients?Safety issues around misuse of antiepileptics.USL255 extended-release topiramate for the treatment of epilepsy.Topiramate Extended Release: A Review in Epilepsy.Adjunctive perampanel in adolescents with inadequately controlled partial-onset seizures: A randomized study evaluating behavior, efficacy, and safety.Factors limiting adherence to antiepileptic treatment: A French online patient survey.Early specialized care after a first unprovoked epileptic seizure.Demographic and Clinical Correlates of Seizure Frequency: Findings from the Managing Epilepsy Well Network Database.Assessing the pharmaceutical care issues of antiepileptic drug therapy in hospitalised epileptic patients
P2860
Q24234637-8AE4278F-FDFF-4E57-9FC7-016DA06D8337Q24241236-F6A46A0D-CA0C-45C3-A59E-0ED920237D74Q30244080-58EF1EEA-E0A9-40B6-A100-A6168B155AA8Q33860089-0FD35CF0-203D-4A1C-96C4-BE9C2E0D46FCQ35245431-2F0AA95F-3080-4F91-886D-75A3E589DC9CQ36269043-20D2F4DC-220A-45BF-9277-9F1FA30E402AQ36555362-811FCCAD-A633-49B6-8B68-EFAD4AC7ACABQ37296950-9C891C59-D449-4AB3-A31D-45D87A4511FCQ37526902-348ED5CF-24ED-4416-ACE6-0727F463DCEDQ37756144-253454F1-424A-4374-80A0-FF1A31E9A59DQ38056165-EC46E8E6-32D4-4507-8A98-060DE5D4BA27Q38103947-3B3781EC-6296-4DEA-B2DC-D59A25F4DA8DQ38249142-2AC3774B-9A97-4AEC-971F-EFB897648252Q38844247-7BB2CA28-49DA-483A-A9FD-315E446300B0Q46408856-2FA19CDE-BC8D-4BBB-955D-0C9BEABEE624Q48304482-7ADFCCC1-40BD-4D3B-8F43-2323C58C7772Q48525579-C41B2A16-C8BE-4781-B85D-6DAC29FFAB1EQ52674605-A2FD42C9-9BD4-4F2F-928B-D8A974CD9A2CQ57928405-3476BCFE-EC9E-4ADB-99D1-EF0FD9A4AB0B
P2860
Managing patient adherence and quality of life in epilepsy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Managing patient adherence and quality of life in epilepsy.
@en
Managing patient adherence and quality of life in epilepsy.
@nl
type
label
Managing patient adherence and quality of life in epilepsy.
@en
Managing patient adherence and quality of life in epilepsy.
@nl
prefLabel
Managing patient adherence and quality of life in epilepsy.
@en
Managing patient adherence and quality of life in epilepsy.
@nl
P2860
P1476
Managing patient adherence and quality of life in epilepsy.
@en
P2093
Gus A Baker
Joanne Eatock
P2860
P304
P356
10.2147/NEDT.2007.3.1.117
P407
P577
2007-02-01T00:00:00Z